AFT Forsyth & Company’s Teladoc Health TDOC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q2
Sell
-3,135
Closed -$226K 148
2022
Q1
$226K Sell
3,135
-2,505
-44% -$180K 0.14% 142
2021
Q4
$518K Sell
5,640
-485
-8% -$58K 0.27% 104
2021
Q3
$777K Sell
6,125
-578
-9% -$84.2K 0.42% 71
2021
Q2
$1.11M Buy
6,703
+865
+15% +$140K 0.6% 51
2021
Q1
$1.06M Buy
5,838
+767
+15% +$178K 0.64% 48
2020
Q4
$1.01M Buy
5,071
+3,981
+365% +$809K 0.63% 49
2020
Q3
$239K Buy
+1,090
New +$231K 0.18% 120

Other funds holding TDOC

AFT Forsyth & Company's TDOC Position: Q2 2022 in Review

AFT Forsyth & Company sold out of Teladoc Health (TDOC) in Q2 2022, closing a stake of 3,135 shares — an estimated $226K sold.

AFT Forsyth & Company first reported a position in TDOC in Q3 2020 and held it in 7 quarters. The position peaked at $1.11M in Q2 2021. 551 funds tracked by Wall St. Rank hold TDOC as of Q2 2022.

  • AFT Forsyth & Company reported no remaining Teladoc Health position as of Q2 2022 after selling out during the quarter.
  • AFT Forsyth & Company sold 3,135 Teladoc Health shares in Q2 2022, an estimated $226K.
  • AFT Forsyth & Company first reported a position in Teladoc Health in Q3 2020 and held it in 7 quarters.
  • AFT Forsyth & Company's Teladoc Health position peaked at $1.11M in Q2 2021.
  • 551 funds tracked by Wall St. Rank held Teladoc Health as of Q2 2022.

Based on AFT Forsyth & Company's 13F filing for Q2 2022, filed 28 Jul 2022.